Technical Articles
TR-FRET
Plate Design for Binding Assays with Biotinylated CRBN/DDB1: Four Control Classes and Three Troubleshooting Points
A practical plate-design guide for CRBN/DDB1 binding experiments: streptavidin capture orientation, TR-FRET and SPR formats, controls and troubleshooting.
View details
- Drug Research
- biotinylated CRBN DDB1
- TR-FRET
- SPR
- BLI
- streptavidin
- ternary complex
- assay controls
- UA080262
How to Choose Biotinylated CRBN/DDB1: A Seven-Step Selection Checklist for PROTAC Studies
A seven-step selection checklist for biotinylated CRBN/DDB1: biotin site, complex assembly, activity validation, plate compatibility and vendor questions that matter.
View details
- Drug Research
- CRBN/DDB1 selection
- biotinylation
- PROTAC screening
- TR-FRET
- binding assay
- checklist
- UA080262
What Is Biotinylated CRBN/DDB1: How the Labeled Complex Serves PROTAC Degradation Research
Biotinylated CRBN/DDB1 is the substrate-recognition module of CRL4 E3 ligase, immobilized for binding assays. This article explains its role in PROTAC and molecular-glue studies.
View details
- Drug Research
- Biotinylated CRBN/DDB1
- CRL4
- E3 ligase
- PROTAC
- molecular glue
- TR-FRET
- ternary complex
- UA080262
CRBN-DDB1 In Vitro Research Tools: Assembly Assessment, Ubiquitination Assays and Failure Points
A tool-oriented guide to CRBN-DDB1 in vitro experiments: assembly quality assessment (SEC/SDS-PAGE), binding and ubiquitination assay parameters, four common failure points and layered troubleshooting strategies.
View details
- Drug Research
- CRBN-DDB1 assay
- In vitro ubiquitination
- TR-FRET
- SPR
- Size exclusion chromatography
- UA085062
KRAS Drug Screening and Bioanalytical Technology Platform—From Recombinant Proteins to Cellular Functional Assays
The development of KRAS-targeted drugs relies on a variety of biochemical and cellular analytical platforms. From the production and quality control of target proteins, to the measurement of compound binding affinity with KRAS, and the validation of signaling pathway inhibition in cells, a standardized analytical process is an essential infrastructure for new drug discovery.
View details
- Cancer
- Recombinant KRAS protein
- nucleotide exchange assay
- TR-FRET
- RAS-RAF binding assay
- cell proliferation assay
- efficacy evaluation model
Time-Resolved Fluorescence Resonance Energy Transfer Technology: Principles, Applications, and Recent Advances
Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) is a highly sensitive biophysical technique that combines time-resolved fluorescence detection with the principle of Förster resonance energy transfer.
View details
- Drug Research
- TR-FRET
- Drug Discovery
- Homogeneous Technology
- Wash-free
Technical Principle and Application Analysis of TR-FRET cAMP High-Range Detection Kit
Cyclic adenosine monophosphate, as an important second messenger molecule within cells, directly reflects the activation or inhibition state of the G protein-coupled receptor signaling pathway.
View details
- Drug Research
- TR-FRET
- Cyclic Adenosine Monophosphate
- cAMP High Range Detection
Technical Analysis of TR-FRET IgG Sandwich Assay Kits
Time-resolved fluorescence resonance energy transfer is a homogeneous detection technique based on non-radiative energy transfer between fluorescent donor and acceptor molecules. The core of this technology lies in the use of lanthanide chelates as fluorescent donors, with common lanthanide elements including europium and terbium.
View details
- Immunity/Inflamma
- TR-FRET
- IgG Sandwich Detection Kit
- Immunoglobulin G
TR-FRET-based KRAS [G13D]/CRBN PROTAC interaction detection technology
The KRAS gene, a member of the RAS family with the highest mutation frequency, plays a critical driving role in the occurrence and development of various malignant tumors.
View details
- Cancer
- KRAS [G13D]/CRBN
- Malignant Tumor
- TR-FRET
TR-FRET Homogeneous Time-Resolved Fluorescence Technology: Principle and Applications
Homogeneous time-resolved fluorescence technology is a novel detection platform that integrates the two core technologies of time-resolved fluorescence and fluorescence resonance energy transfer, and has wide applications in drug screening, life science research, and clinical diagnostics.
View details
- Drug Research
- TR-FRET
- Homogeneous time-resolved fluorescence technology
- Drug screening
- 1
- 2








![基于TR-FRET的KRAS [G13D]/CRBN PROTAC相互作用检测技术](https://univ-shop.oss-cn-shanghai.aliyuncs.com/pc/images/20260415/caaa95eae2ba49b791d4b1565a9c47c7.png)






